Cargando…

Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia

Recent interest in mushrooms and their components as potential therapies for mental health, along with recent government and health authority approvals, has necessitated a more comprehensive understanding of their effects on the cellular microenvironment of the brain. Amanita muscaria has been inges...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Ashley, Pehar, Marcus, Yan, Zhimin, Kulka, Marianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130647/
https://www.ncbi.nlm.nih.gov/pubmed/37124206
http://dx.doi.org/10.3389/fphar.2023.1102465
_version_ 1785031003035664384
author Wagner, Ashley
Pehar, Marcus
Yan, Zhimin
Kulka, Marianna
author_facet Wagner, Ashley
Pehar, Marcus
Yan, Zhimin
Kulka, Marianna
author_sort Wagner, Ashley
collection PubMed
description Recent interest in mushrooms and their components as potential therapies for mental health, along with recent government and health authority approvals, has necessitated a more comprehensive understanding of their effects on the cellular microenvironment of the brain. Amanita muscaria has been ingested as a treatment for a variety of ailments for centuries, most notably those affecting the central nervous system and conditions associated with neuroinflammation. However, the effects of these extracts on neuroinflammatory cells, such as microglia, are unknown. The effect of commercially-sourced A. muscaria extract (AME-1) on human microglial cell line (HMC3) expression of surface receptors such as CD86, CXCR4, CD45, CD125 and TLR4 was determined by flow cytometry. AME-1 upregulated expression of all of these receptors. The effect of AME-1 on HMC3 production of IL-8 and IL-6 was determined and compared to tumor necrosis factor (TNF), polyinosinic-polycytidylic acid [poly(I:C)], substance P and lipopolysaccharide (LPS), all known activators of HMC-3 and primary microglia. HMC3 produced both IL-8 and IL-6 when activated with LPS, TNF and poly(I:C) but not when they were activated with substance P. Although AME-1 at higher concentrations increased IL-8 production of HMC3 on its own, AME-1 notably potentiated HMC3 production of IL-8 in response to poly(I:C). AME-1 altered expression of toll-like receptor 3 (TLR3) mRNA but not surface protein by HMC3. AME-1 also did not significantly alter expression of retinoic acid-inducible gene I (RIG-I) or melanoma differentiation-associated protein 5 (MDA5), both cytosolic sensors of dsRNA. Metabolomics analysis showed that AME-1 contained several metabolites, including the autophagy inducer, trehalose. Like AME-1, trehalose also potentiated HMC3 poly(I:C) mediated production of IL-8. This study suggests that A. muscaria extracts can modify HMC3 inflammatory responses, possibly due to their trehalose content.
format Online
Article
Text
id pubmed-10130647
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101306472023-04-27 Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia Wagner, Ashley Pehar, Marcus Yan, Zhimin Kulka, Marianna Front Pharmacol Pharmacology Recent interest in mushrooms and their components as potential therapies for mental health, along with recent government and health authority approvals, has necessitated a more comprehensive understanding of their effects on the cellular microenvironment of the brain. Amanita muscaria has been ingested as a treatment for a variety of ailments for centuries, most notably those affecting the central nervous system and conditions associated with neuroinflammation. However, the effects of these extracts on neuroinflammatory cells, such as microglia, are unknown. The effect of commercially-sourced A. muscaria extract (AME-1) on human microglial cell line (HMC3) expression of surface receptors such as CD86, CXCR4, CD45, CD125 and TLR4 was determined by flow cytometry. AME-1 upregulated expression of all of these receptors. The effect of AME-1 on HMC3 production of IL-8 and IL-6 was determined and compared to tumor necrosis factor (TNF), polyinosinic-polycytidylic acid [poly(I:C)], substance P and lipopolysaccharide (LPS), all known activators of HMC-3 and primary microglia. HMC3 produced both IL-8 and IL-6 when activated with LPS, TNF and poly(I:C) but not when they were activated with substance P. Although AME-1 at higher concentrations increased IL-8 production of HMC3 on its own, AME-1 notably potentiated HMC3 production of IL-8 in response to poly(I:C). AME-1 altered expression of toll-like receptor 3 (TLR3) mRNA but not surface protein by HMC3. AME-1 also did not significantly alter expression of retinoic acid-inducible gene I (RIG-I) or melanoma differentiation-associated protein 5 (MDA5), both cytosolic sensors of dsRNA. Metabolomics analysis showed that AME-1 contained several metabolites, including the autophagy inducer, trehalose. Like AME-1, trehalose also potentiated HMC3 poly(I:C) mediated production of IL-8. This study suggests that A. muscaria extracts can modify HMC3 inflammatory responses, possibly due to their trehalose content. Frontiers Media S.A. 2023-04-12 /pmc/articles/PMC10130647/ /pubmed/37124206 http://dx.doi.org/10.3389/fphar.2023.1102465 Text en Copyright © 2023 Wagner, Pehar, Yan and Kulka. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wagner, Ashley
Pehar, Marcus
Yan, Zhimin
Kulka, Marianna
Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia
title Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia
title_full Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia
title_fullStr Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia
title_full_unstemmed Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia
title_short Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia
title_sort amanita muscaria extract potentiates production of proinflammatory cytokines by dsrna-activated human microglia
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130647/
https://www.ncbi.nlm.nih.gov/pubmed/37124206
http://dx.doi.org/10.3389/fphar.2023.1102465
work_keys_str_mv AT wagnerashley amanitamuscariaextractpotentiatesproductionofproinflammatorycytokinesbydsrnaactivatedhumanmicroglia
AT peharmarcus amanitamuscariaextractpotentiatesproductionofproinflammatorycytokinesbydsrnaactivatedhumanmicroglia
AT yanzhimin amanitamuscariaextractpotentiatesproductionofproinflammatorycytokinesbydsrnaactivatedhumanmicroglia
AT kulkamarianna amanitamuscariaextractpotentiatesproductionofproinflammatorycytokinesbydsrnaactivatedhumanmicroglia